EXTH-25. THE CSF PENETRATION OF THE PROCASPASE-ACTIVATING COMPOUND (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN A NONHUMAN PRIMATE CSF ACCESS MODEL

Ítems similars

• EXTH-57. PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS OF THE PROCASPASE-ACTIVATING COMPOUND, PAC-1, FOLLOWING ORAL ADMINISTRATION IN A NON-HUMAN PRIMATE MODEL
  per: McCully, Cynthia Lester, et al.
  Publicat: (2018)
• HG-36 PLASMA AND CEREBROSPINAL FLUID (CSF) PHARMACOKINETICS OF PANOBINOSTAT FOLLOWING ORAL ADMINISTRATION TO NONHUMAN PRIMATES
  per: Rodgers, Louis, et al.
  Publicat: (2016)
• Quantification of Temozolomide in Nonhuman Primate Fluids by Isocratic Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry to Study Brain Tissue Penetration Following Intranasal or Intravenous Delivery
  per: Peer, Cody J., et al.
  Publicat: (2016)
• EXTH-54. ENHANCED SENSITIVITY OF HUMAN GLIOMA CELLS FOR TEMOZOLOMIDE (TMZ) BY COMBINING THERAPY WITH HEAT SHOCK PROTEIN 90
  per: Sharma, Pratibha, et al.
  Publicat: (2020)
• PHRM-03. CEREBROSPINAL FLUID PENETRATION OF PEXIDARTINIB (PLX3397), A CSF1R INHIBITOR, IN A NONHUMAN PRIMATE MODEL
  per: Odabas, Arman, et al.
  Publicat: (2018)